Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1446159/000117184324001694/poai20231231_10k.htm
May 2024
April 2024
March 2024
February 2024
January 2024
November 2023
August 2023
August 2023
May 2023
May 2023
Document And Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Mar. 18, 2024 | Jun. 30, 2023 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Transition Report | false | ||
Entity File Number | 001-36790 | ||
Entity Registrant Name | Predictive Oncology Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 33-1007393 | ||
Entity Address, Address Line One | 91 43rd Street, Suite 110 | ||
Entity Address, City or Town | Pittsburgh | ||
Entity Address, State or Province | PA | ||
Entity Address, Postal Zip Code | 15201 | ||
City Area Code | 412 | ||
Local Phone Number | 432-1500 | ||
Title of 12(b) Security | Common stock, $0.01 par value | ||
Trading Symbol | POAI | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 18,983,374 | ||
Entity Common Stock, Shares Outstanding (in shares) | 4,062,853 | ||
Auditor Name | BDO USA, P.C. | ||
Auditor Location | Minneapolis, Minnesota | ||
Auditor Firm ID | 243 | ||
Entity Central Index Key | 0001446159 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1446159/000117184324001694/poai20231231_10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Predictive Oncology Inc..
Predictive Oncology Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Predictive Oncology Inc. provided additional information to their SEC Filing as exhibits
Ticker: POAI
CIK: 1446159
Form Type: 10-K Annual Report
Accession Number: 0001171843-24-001694
Submitted to the SEC: Thu Mar 28 2024 5:28:42 PM EST
Accepted by the SEC: Thu Mar 28 2024
Period: Sunday, December 31, 2023
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies